Submitted:
02 July 2026
Posted:
02 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Results and Discussion
2.1. Synthesis and Crystal Structures
2.2. The Structural Information about Complexes 1-3

2.3. Stability in DMSO Solutions
2.4. Photoinduced NO Release
2.5. TD-DFT Calculations

2.6. Electrospray Mass-Spectroscopy of the Solutions After Photolysis


2.7. The Crustal Structure of NO Release Product for Bipyridine Complex 5
3. Materials and Methods
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R. L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. [CrossRef]
- Rosenberg, B.; Vancamp, L.; Trosko, J. E.; Mansour, V. H. Platinum Compounds: A New Class of Potent Antitumour Agents. Nature 1969, 222 (5191), 385–386. [CrossRef]
- Johnstone, T. C.; Suntharalingam, K.; Lippard, S. J. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem. Rev. 2016, 116 (5), 3436–3486. [CrossRef]
- Bergamo, A.; Gaiddon, C.; Schellens, J. H. M.; Beijnen, J. H.; Sava, G. Approaching Tumour Therapy beyond Platinum Drugs: Status of the Art and Perspectives of Ruthenium Drug Candidates. Journal of Inorganic Biochemistry 2012, 106 (1), 90–99. [CrossRef]
- Alessio, E. Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective. European Journal of Inorganic Chemistry 2017, 2017 (12), 1549–1560. [CrossRef]
- Hartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K. KP1019, A New Redox-Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients. Chemistry & Biodiversity 2008, 5 (10), 2140–2155. [CrossRef]
- Monro, S.;Colón, K. L.; Yin, H.; Roque, J. I.; Konda, P.; Gujar, S.; Thummel, R. P.; Lilge, L.; Cameron, C. G.; McFarland, S. A. Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. Chem. Rev. 2019, 119 (2), 797–828. [CrossRef]
- Ignarro, L. J. Nitric Oxide as a Unique Signaling Molecule in the Vascular System: A Historical Overview. J Physiol Pharmacol 2002, 53 (4 Pt 1), 503–514.
- Wink, D. A.; Mitchell, J. B. Chemical Biology of Nitric Oxide: Insights into Regulatory, Cytotoxic, and Cytoprotective Mechanisms of Nitric Oxide. Free Radical Biology and Medicine 1998, 25 (4), 434–456. [CrossRef]
- Bonavida, B.; Khineche, S.; Huerta-Yepez, S.; Garbán, H. Therapeutic Potential of Nitric Oxide in Cancer. Drug Resistance Updates 2006, 9 (3), 157–173. [CrossRef]
- Fukumura, D.; Kashiwagi, S.; Jain, R. K. The Role of Nitric Oxide in Tumour Progression. Nat Rev Cancer 2006, 6 (7), 521–534. [CrossRef]
- Ford, P. C. Photochemical Delivery of Nitric Oxide. Nitric Oxide 2013, 34, 56–64. [CrossRef]
- Rose, M. J.; Mascharak, P. K. Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors. Coordination Chemistry Reviews 2008, 252 (18), 2093–2114. [CrossRef]
- Roncaroli, F.; Videla, M.; Slep, L. D.; Olabe, J. A. New Features in the Redox Coordination Chemistry of Metal Nitrosyls {M–NO+; M–NO; M–NO−(HNO)}. Coordination Chemistry Reviews 2007, 251 (13), 1903–1930. [CrossRef]
- Levina, A.; Mitra, A.; Lay, P. A. Recent Developments in Ruthenium Anticancer Drugs. Metallomics 2009, 1 (6), 458–470. [CrossRef]
- Fairy, M. B.; Irving, R. J. Complexes of Ruthenium Nitrosyl Trihalides. Journal of the Chemical Society A: Inorganic, Physical, Theoretical 1966, 0 (0), 475–479. [CrossRef]
- Haukka, M.; Venäläinen, T.; Ahlgrén, M.; Pakkanen, T. A. Reactions of [Ru(Bpy)(CO)2Cl2] in Acidic Media: Formation and Structural Characterization of [Ru(Bpy)Cl3(NO)], [Ru2N(Bpy)2Cl5(H2O)], and (H5O2)[Ru2N(Bpy)2Cl6]. Inorganic Chemistry 2002, 34 (11), 2931–2936. [CrossRef]
- Emel’yanov, V. A.; Fedotov, M. A.; Belyaev, A. V.; Tkachev, S. V. A Multinuclear Magnetic Resonance Study of Transformations of Ruthenium(II) Nitrosyl Chloride Complexes in Aqueous Solutions. Physical methods of investigation. Russian Journal of Inorganic Chemistry 2013, 58 (8), 1073–1081. [CrossRef]
- Hirano, T.; Ueda, K.; Mukaida, M.; Nagao, H.; Oi, T. Reactions of [RuCl2(NO)(Terpy)]+ ( Terpy = 2,2′ : 6′,2″-Terpyridine) with Mono Anions Such as NO 2 − , Br − and N 3 − , and Structural Studies on Terpyridineruthenium Having a Nitrosyl Ligand. Journal of the Chemical Society, Dalton Transactions 2001, 0 (16), 2341–2345. [CrossRef]
- Brovko, A. O.; Yakovlev, I. A.; Kuratieva, N. V.; Sheven, D. G.; Kostin, G. A. Ruthenium Nitrosyl Complexes with Bidentate Heterocycles: Synthesis and Their Transformations in Solution. Dalton Trans. 2026. [CrossRef]
- Mikhailov, A. A.; Stolyarova, E. D.; Kostin, G. A. Photochemistry of ruthenium nitrosyl complexes in solids and solutions and its potential applications. Journal of Structural Chemistry 2021 62:4 2021, 62 (4), 497–516. [CrossRef]
- Yakovlev, I. A.; Mikhailov, A. A.; Eremina, J. A.; Klyushova, L. S.; Nadolinny, V. A.; Kostin, G. A. Nitric Oxide Release and Related Light-Induced Cytotoxicity of Ruthenium Nitrosyls with Coordinated Nicotinate Derivatives. Dalton Trans. 2021, 50 (38), 13516–13527. [CrossRef]
- Mikhailov, A. A.; Vorobyev, V. A.; Nadolinny, V. A.; Patrushev, Y. V.; Yudina, Y. S.; Kostin, G. A. Primary and Secondary Photochemical Transformations of Biologically Active Precursor - Nitro-Nitrosyl Ruthenium Complex. Journal of Photochemistry and Photobiology A: Chemistry 2019, 373, 37–44. [CrossRef]
- Fawcett, W. R. Acidity and Basicity Scales for Polar Solvents. J. Phys. Chem. 1993, 97 (37), 9540–9546. [CrossRef]
- Balzani, V.; Bergamini, G.; Campagna, S.; Puntoriero, F. Photochemistry and Photophysics of Coordination Compounds: Overview and GeneralConcepts. In Photochemistry and Photophysics of Coordination Compounds I; Balzani, V., Campagna, S., Eds.; Springer: Berlin, Heidelberg, 2007; pp 1–36. [CrossRef]
- Stepanenko, I.; Zalibera, M.; Schaniel, D.; Telser, J.; Arion, V. B. Ruthenium-Nitrosyl Complexes as NO-Releasing Molecules, Potential Anticancer Drugs, and Photoswitches Based on Linkage Isomerism. Dalton Transactions 2022, 51 (14), 5367–5393. [CrossRef]
- Bukhanko, V.; Lacroix, P. G.; Sasaki, I.; Tassé, M.; Mallet-Ladeira, S.; Voitenko, Z.; Malfant, I. Mechanism and Oxidation State Involved in the Nitric Oxide (NO) Photorelease in a Terpyridine-Bipyridine-Based Ruthenium Nitrosyl Complex. Inorganica Chimica Acta 2018, 482, 195–205. [CrossRef]









| 1(fac-bpym) | 2(fac-phen) | 3(mer-phen) | |
| Space group | P21/n | P212121 | P21/n |
| d(N-O), Å | 1.132(2) | 1.139(4) | 1.132(5) |
| Ð(Ru-N-O), ° | 168.90(16) | 170.8(3) | 172.4(4) |
| d(Ru-NO), Å | 1.7435(17) | 1.746(3) | 1.742(4) |
| d(Ru-Cl), Å | 2.3572(5) 2.3628(5) 2.3462(5) (trans) |
2.3759(10) 2.3813(9) 2.3460(10) (trans) | 2.3624(14) 2.3502(15) 2.3586(14) |
| d(Ru-N(L)), Å | 2.0815(16) 2.0816(16) |
2.076(3) 2.082(3) |
2.084(4) 2.097(5) (trans) |
| Compound | QY, % |
| fac-[RuNO(bpym)Cl3] (1) | 5.4 ± 0.5 |
| fac-[RuNO(phen)Cl₃] (2) | 0.8±0.1 |
| mer-[RuNO(phen)Cl3] (3) | 0.6±0.1 |
| fac-[RuNO(bpy)Cl3] (4) | 3.7±0.1 |
| mer-[RuNO(bpy)Cl3] (5) | 2.1±0.1/2.4±0.1 (DMSO/CH3CN) |
| Complex | RC, % | QY, % |
| 2 (fac-) | 32 | 0.8±0.1 |
| 3 (mer-) | 23 | 0.6±0.1 |
| 4 (fac-) | 63 | 3.7±0.1 |
| 5 (mer-) | 44 | 2.1±0.1 |
| Compound | m/z of (*) | Proposed Fragment Composition of (*) |
| fac-[RuNO(bpym)Cl3] (1) | 529 | [Ru(bpym)(DMSO)3Cl]+ |
| fac-[RuNO(phen)Cl₃] (2) | 510 | [Ru(phen)(DMSO)2Cl2]+ |
| mer-[RuNO(phen)Cl3] (3) | ||
| fac-[RuNO(bpy)Cl3] (4) | 486 | [Ru(bpy)(DMSO)2Cl2]+ |
| mer-[RuNO(bpy)Cl3] (5) |
| 6 | 5* | |
| Space group | P-1 | Pn |
| Ð(Ru-N-CCH3), ° | 173.3(7) | 174.01 |
| d(Ru-N), Å | 2.056(7) | 1.938 |
| d(Ru-Cl), Å | 2.353(2) 2.363(2) 2.314(2) |
2.356 2.349 2.336 |
| d(Ru-N(L)), Å | 2.054(7) 2.037(6) (trans) |
2.079 2.100 (trans) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).